Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Eris Lifesciences Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 08 Nov 2023 | Eris Lifesciences to Acquire Dermatology and Nephrology branded formulations business units from Biocon Biologics for USD43.9 Million | Asset Transaction |
Eris Lifesciences Ltd
|
Biocon Biologics Ltd
|
| 08 Nov 2023 | EEris Lifesciences to Acquire Nephrology and Dermatology Branded Formulations Business Units from Biocon Biologics | Asset Transaction |
Eris Lifesciences Ltd
|
Biocon Biologics Ltd
|
| 17 Jul 2023 | Eris Lifesciences Ltd Enters Phase IV Clinical Trial Agreement with Clinwave Research Pvt Ltd for vildagliptin (GDCT0492749) | Contract Service Agreement |
Eris Lifesciences Ltd
|
Clinwave Research Pvt Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer